4.7 Article

A gain-of-function variation in PLCG1 causes a new immune dysregulation disease

Related references

Note: Only part of the references are listed.
Article Immunology

G-CSF drives autoinflammation in APLAID

Elisabeth Mulazzani et al.

Summary: Missense mutations in PLCG2 can lead to autoinflammation with phospholipase C gamma 2-associated antibody deficiency and immune dysregulation. A mouse model carrying the APLAID mutation (p.Ser707Tyr) showed partial improvement in inflammatory infiltrates with inflammasome removal. Increased G-CSF levels were found in APLAID mice and individuals, which can be reversed by treatment with a G-CSF antibody.

NATURE IMMUNOLOGY (2023)

Article Rheumatology

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation

Kai Yan et al.

Summary: This study reveals that PSMD12 haploinsufficiency causes inflammation signatures in addition to neurodevelopmental disorders, expanding the genotype and phenotype spectrum of PRAAS.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease

Jun Wang et al.

Summary: The study identified a somatic NLRC4 mutation as the genetic basis for a late-onset autoinflammatory disease, leading to enhanced inflammatory response, and highlighted the potential novel treatment strategy of targeting gasdermin D to suppress inflammatory cytokine production.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Urology & Nephrology

Effector Memory?Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor?Dependent Proinflammatory and Migratory Responses

Tra-My Doan Ngoc et al.

Summary: Our study reveals that humoral rejection of kidney transplants is associated with the accumulation of TEMRA CD8(+) T cells in blood and kidney graft biopsies. TEMRA CD8(+) T cells from kidney transplant recipients show enhanced migratory properties compared to EM CD8(+) T cells, with increased adhesion to activated endothelium and transmigration in response to CXCL12 chemokine. Furthermore, IL-15 stimulation promotes the migration of TEMRA and EM CD8(+) T cells induced by CXCL12 and enhances the generation of functional PSGL1, which interacts with P-selectin and facilitates adhesion to activated endothelium. Notably, inhibiting the migration of TEMRA CD8(+) T cells from kidney transplant recipients by targeting VLA-4 or LFA-1 suggests the potential therapeutic benefit of targeting these cells in transplant recipients.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Biochemistry & Molecular Biology

Phospholipase Cγ1 represses colorectal cancer growth by inhibiting the Wnt/β-catenin signaling axis

Kyeong Jin Shin et al.

Summary: The study demonstrates that PLCγ1 serves as a tumor suppressor in vivo, regulating the PIP2 level and the Wnt/β-catenin pathway in colorectal carcinogenesis. PLCγ1 deficiency accelerates colorectal tumor formation and is associated with poor prognosis in colon cancer patients.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onto-driver and novel therapeutic target in human carcinogenesis

Supratim Mandal et al.

Summary: Phosphoinositide metabolism is a critical intracellular signaling system that regulates various biological functions, and PLCγ1, as a member of the PLC family, plays a crucial role in tumorigenesis by modulating cell survival, migration, invasion, and angiogenesis. The aberrant expression and regulation of PLCγ1 are linked to a range of deadly human cancers, highlighting its significance as a potential therapeutic target in cancer research. Further studies are needed to fully understand PLCγ1's precise role in carcinogenesis and its potential as a novel treatment target.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Multidisciplinary Sciences

Deubiquitination of proteasome subunits by OTULIN regulates type I IFN production

Panfeng Tao et al.

Summary: OTULIN deficiency leads to activation of NF-κB and IFN-I signaling pathways, caused by dysregulated proteasomes due to the deubiquitinase activity of OTULIN. This suggests a crucial role of linear ubiquitination in regulating proteasome function and its link to autoinflammatory syndromes associated with proteasome dysfunction.

SCIENCE ADVANCES (2021)

Review Rheumatology

Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases

Ivona Aksentijevich et al.

Summary: Monogenic autoinflammatory diseases are rheumatologic disorders caused by dysregulation in the innate immune system, with molecular mechanisms related to defects in various inflammatory signalling pathways. Disease presentation can vary due to genetic differences, and the phenotype may be more deleterious in specific cell types.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Multidisciplinary Sciences

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1

Panfeng Tao et al.

NATURE (2020)

Article Medicine, General & Internal

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

David B. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer

Adam Bartok et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Development of a Validated Interferon Score Using NanoString Technology

Hanna Kim et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)

Article Immunology

B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6

Shaun W. Jackson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Multidisciplinary Sciences

Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease

Qing Zhou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Letter Allergy

Somatic NOD2 mosaicism in Blau syndrome

[Anonymous]

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Hematology

PLCG1 mutations in cutaneous T-cell lymphomas

Jose P. Vaque et al.

BLOOD (2014)

Article Genetics & Heredity

Recurrent PTPRB and PLCG1 mutations in angiosarcoma

Sam Behjati et al.

NATURE GENETICS (2014)

Article Medicine, General & Internal

Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2

Qing Zhou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Biochemistry & Molecular Biology

Dysfunction of phospholipase Cγ in immune disorders and cancer

Hans Koss et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Article Medicine, General & Internal

Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions

Michael J. Ombrello et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

John C. Hall et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Immunology

Phospholipase Cγ1 is essential for T cell development, activation, and tolerance

Guoping Fu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Medicine, General & Internal

An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist

Ivona Aksentijevich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Biochemistry & Molecular Biology

Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice

HJ Liao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)